By Dan Keating, Peter Whoriskey and Pam Tobey, Published: Dec. 7, 2013
The drugs Avastin and Lucentis are extremely similar, including in how well they treat a common form of blindness in seniors. But in price they are vastly different — about $50 per treatment vs. about $2,000. Both drugs are made by the same company, Genentech, but the less expensive drug is not packaged in dosage sizes for eye treatment and has never been submitted for federal Food and Drug Administration approval to treat eyes.
SOURCE: Washington Post analysis of Medicare Part B claims data.